AzTrials
AzTrials

Obesity, ChildhoodRx SLEEPNCT06810557

Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care

A study testing Optimize Sleep Primary Care (OSPC) in people with Obesity, Childhood and Short Sleep, run by Temple University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to compare two different approaches to help families with children 6-11 years enhance nighttime sleep: 1) working one-on-one with a nurse to learn effective behavioral strategies to try to improve children's sleep or 2) receiving education on a good night's sleep and its benefits. Read more about this study

Who is it for?
Ages 6 to 11 years
What is being tested?
Optimize Sleep Primary Care (OSPC)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
15 May 2025to 31 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patient at Temple Pediatrics
  • Child age 6-11 years
  • Child time in bed of less than 9 hours per night on most days per week
  • Body Mass Index (BMI) for age and biological sex great than the 10th percentile but less than the 95th percentile
  • Understanding of and ability to complete the protocol
  • Parent age at least 18 years and primary caregiver
  • Willingness to be randomized to either condition

Who cannot join

  • Diagnosed sleep disorder
  • Medication use or diagnosis of medical or psychiatric condition that may impact sleep or weight status
  • Current or planned treatment for weight control

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ashley Ogoe, MPH, CCRP contact

215-707-5782

ashley.greer@temple.edu

Chantelle N Hart, PhD contact

215-707-8639

chantelle.hart@temple.edu

United States1 site, 1 recruiting
  • Temple Pediatrics

    Philadelphia, Pennsylvania, 19140

    Ashley Ogoe, MPH, 215-707-5782, ashley.greer@temple.edu

    Recruiting

Other trials in United States

About this study

Official title: Feasibility and Preliminary Efficacy of a Brief Behavioral Sleep Intervention for Excessive Weight Gain Prevention in Primary Care

The goal of this study is to compare two different approaches to help families with children 6-11 years enhance nighttime sleep: 1) working one-on-one with a nurse to learn effective behavioral strategies to try to improve children's sleep or 2) receiving education on a good night's sleep and its benefits. Participating families will meet with a nurse 6 times or receive 6 educational handouts. Participating families will also complete three assessments (start of the study, 2 months and 6 months) during which study questionnaires will be completed, participating children will wear devices that assess sleep and physical activity, participating families will report on what the child ate on two separate days and will be measured for height and weight.

Read the detailed description

The present study is assessing the feasibility and preliminary effectiveness of a brief behavioral intervention to enhance children's sleep and prevent development of obesity. Fifty short sleeping (< 9 hours/night) children 6-11 years old who are primarily AA/Black and from lower socioeconomic backgrounds will be enrolled into a 6-month study. Children will be randomly assigned to 1 of 2 conditions: 1) optimize sleep primary care (OSPC; behavioral intervention to enhance sleep duration delivered by a nurse in primary care) or 2) enhanced usual care (EUC; usual care plus sleep education). All children will receive standard pediatric care. Families randomized to OSPC will receive a four-session intervention (two zoom-delivered sessions and two brief phone follow-ups) over the first two months with two additional phone follow-ups during maintenance (months 2-6). Families randomized to EUC will receive sleep education that is delivered at the same points of contact as OSPC sessions. At baseline, end of treatment (2 months), and 6 months, the following will be measured from a Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) perspective: reach (e.g., enrollment), adoption (e.g., pediatric provider engagement), implementation (e.g., session attendance, treatment fidelity), maintenance (e.g., retention), and preliminary effectiveness (e.g., changes in sleep duration (actigraphy), eating behaviors (24-hour dietary recalls), physical activity (accelerometry), and anthropometrics (measured height and weight).

Being tested
Optimize Sleep Primary Care (OSPC), Enhanced Usual Care
Keywords
sleep, behavioral intervention, primary care, obesity prevention, child, pediatric
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Optimize Sleep Primary Care (OSPC)Behavioural

    In addition to standard care within Temple University Primary Care (TUPC), two face-to-face zoom sessions and four brief phone follow-ups (two during active treatment and two during maintenance) that focus on using effective behavioral strategies (e.g., goal setting, self-monitoring, positive reinforcement, stimulus control, problem-solving) to enhance children's sleep by approximately one hour/night.

  • Enhanced Usual CareOther

    In addition to standard care within Temple University Primary Care (TUPC), the provision of six education contacts regarding children's sleep needs and the benefits of getting a good night's sleep.

Study groups in NCT06810557
Study groupRoleWhat they receive
Behavioral Sleep InterventionExperimentalBehavioral intervention to enhance school-aged children's sleep
Receives: Behavioral: Optimize Sleep Primary Care (OSPC)
Sleep EducationOtherSleep Education
Receives: Other: Enhanced Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Achievement of enrollment goal

    Primary variable of interest is achievement of a priori goals for study enrollment (i.e., whether 50 families enroll in the study). We will also explore: of children referred, the number who enroll; and of children who are referred and eligible, the number who enroll.

    Measured: baseline

  2. The number of providers who participate and refer to the intervention

    Of all pediatric providers in the clinic, the number who attend the initial in-service training and the number of referrals each provider makes to the program. Attendance and the number of referrals will be tracked by study staff.

    Measured: baseline

  3. Average family attendance at intervention sessions

    Whether or not families attend each treatment sessions will be captured by the study nurse. Primary variable of interest is whether families, on average, achieve > 75% attendance at all intervention sessions.

    Measured: baseline to 6 months

  4. Nurse percent fidelity/accuracy in delivering the intervention

    All intervention sessions are recorded to determine the accuracy with which nurses deliver the intervention. Specifically, trained staff review recordings and use a checklist to mark whether or not each intervention component is delivered during each session. Primary variable of interest is whether the nurse delivers the intervention with at least 80% fidelity/accuracy.

    Measured: baseline to 6 months

  5. Percent of families who are retained in the study at both follow-up time points

    Retention at both 2- and 6-months will be tracked by study staff and compared across study arms with a goal of at least 80% retention at two months.

    Measured: baseline to 6 months

  6. Family assessment of the intervention's acceptability

    Acceptability will be measured by families' responses to the overall acceptability question on the Theoretical Framework for Acceptability (TFA) Acceptability Scale. Specifically, families use a 5-point, likert-type scale ranging from 'completely unacceptable' to 'completely acceptable' to rate the intervention. The percent of families who rate the intervention as 'acceptable' or 'completely acceptable' will be assessed with a goal of at least 80% of families rating it as such.

    Measured: baseline to 6 months

Secondary outcomes (6)
  1. Preliminary Effectiveness: Sleep

    Measured with actigraphy over 7 days at each assessment and scored with the assistance of sleep diaries and call-ins to time-stamped voicemail. Primary variable of interest is change in the actigraph-estimated sleep period, which is the time between actigraph-estimated bedtime and wake time.

    Measured: baseline to 6 months

  2. Preliminary Effectiveness: Weight Status

    Child height and weight will be measured by staff to calculate body mass index (BMI). Change in BMI (controlling for child age and biological sex) is of primary interest.

    Measured: baseline to 6 months

  3. Preliminary Effectiveness: Diet - Caloric Intake

    Measured with 24-hour dietary recalls on two days (one weekday and one weekend day). Mean reported caloric intake will be computed.

    Measured: baseline to 6 months

  4. Preliminary Effectiveness: Diet - Percent Calories from Fat

    Measured with 24-hour dietary recalls on two days (one weekday and one weekend day). Mean reported percent calories from fat will be computed.

    Measured: baseline to 6 months

  5. Preliminary Effectiveness: Physical Activity

    Measured with hip-worn accelerometry. Time spent in moderate to vigorous physical activity (controlling for wear time) is of primary interest.

    Measured: baseline to 6 months

  6. Preliminary Effectiveness: Sedentary Activity

    Measured by parent and child report during 24-hour dietary recalls (one weekday and one weekend day). Mean hours of TV viewing is of primary interest.

    Measured: baseline to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2025
  2. Study start15 May 2025
  3. Primary completion30 Nov 2026 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06810557
Sponsor's protocol ID
R01DK139665
Other IDs
R01DK139665
Acronym
Rx SLEEP
Status last verified
Feb 2026
First submitted
21 Jan 2025
Last updated
12 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified, cleaned and scored summary data of the following will be shared: parent-completed surveys, child-worn actigraph and accelerometry data, staff-measured parent and child height and weight data, and staff-tracked process data

Questions about this trial

What is this clinical trial studying?

A study testing Optimize Sleep Primary Care (OSPC) in people with Obesity, Childhood and Short Sleep, run by Temple University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ashley Ogoe, MPH, CCRP (215-707-5782, ashley.greer@temple.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Achievement of enrollment goal (time frame: baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in